India's drug regulator is exploring new methods to ensure the quality of high-risk solvents like propylene glycol used in liquid medicines. This comes after several incidents of contaminated cough syrups led to child deaths. The authority is also considering restricting sales by unlicensed pharmacists and seeking expert advice on substituting propylene glycol.